相关实验视频

Updated: Jan 13, 2026

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

基于新抗原的癌症疫苗的进展

An-Chih Wu^1,2, Yusuke Nakamura¹, Kazuma Kiyotani¹

¹Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki-shi, Osaka 567-0085, Japan.

|January 10, 2026

概括

新抗原疫苗,针对患者特定的瘤突变,在个性化癌症治疗方面显示出希望. 与树突细胞 (DCs) 的基疫苗可能比mRNA疫苗提供更好的CD8+T细胞反应.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
疫苗开发疫苗开发

背景情况:

基于新抗原的免疫疗法利用瘤特异性突变进行向癌症治疗.
新抗原使选择性T细胞识别成为可能,最大限度地降低了瘤外毒性.
个性化癌症疫苗正在成为一种关键的治疗策略.

研究的目的:

审查癌症免疫疗法中新抗原疫苗的景观.
为了比较不同新抗原疫苗平台的免疫性和临床结果.
为了确定影响疫苗疗效的因素,如疾病阶段和治疗时间.

主要方法:

对,mRNA和DNA新抗原疫苗的临床试验和比较数据的审查.
分析不同类型疫苗引起的T细胞反应 (CD8+和CD4+).
对各种癌症类型的临床结果的评估,包括无复发生存率.

主要成果:

脉冲树突细胞 (DC) 疫苗显示出比mRNA疫苗更高的CD8+T细胞反应.
由于免疫主导,mRNA疫苗可能会诱导CD4+主导反应.
临床试验显示强大的免疫激活和鼓舞人心的结果在辅助设置黑色素瘤,质母细胞瘤和胰腺癌.
早期疾病和术后疫苗接种与更好的免疫反应相关.

结论:

新抗原疫苗是一种有前途的个性化癌症免疫治疗方法.
疫苗平台的选择 (-DC与mRNA) 影响T细胞反应概况.
优化新抗原预测,制造和治疗时间对于未来的进步至关重要.
新抗原疫苗对下一代癌症治疗策略有很大的前景.

关键词:

通过T细胞治疗治疗.癌症疫苗疫苗癌症疫苗个性化的新抗原分享的新抗原.疫苗平台疫苗平台疫苗平台

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...